The Cannabis Emblem in the Sky: $EMC.V $EMMBF

Emblem Cannabis

Canada’s medical marijuana market, $400 million a year currently, could grow to $1.1 billion by 2020. Compare this to the non-cannabis chronic pain pharmaceutical market which rests at over $500 million, dominated by opioids. The ACMPR (Access to Cannabis for Medical Purpose Regulations) is expanding the mechanisms for approval of cannabinoid based medications, and products such as oils have taken the market by storm. Simple oils have grown to around 35% of the market in less than a year. Emblem … [Read more...]

Emblem Corp To Disrupt $60 Billion Opiod Market With Cannabis Based Sustained Release Formulation

TSXV: EMC

Very big news out of Emblem Corp $EMC.V today, with the halt on this news event lifted tomorrow morning at 5AM PST Oct 4th... This is one to watch: Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation PARIS, Ontario, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the "Company") announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab … [Read more...]

Powering up the Cannabis Industry with Abattis: $ATT.C $ATTBF

ATT1

Stockpools, the CSE and Lift Cannabis Expo have a summer-long challenge underway called “The CSE Cannabis Investment Challenge”, and as usual at Stockpools, there is no cost to join! The Syndicate took a look at title sponsor Abattis Bioceuticals for an overview of the company’s plans and accomplishments within the quickly evolving marijuana industry. Read on for more information on this industry-leader in the cannabis space. Abattis Bioceuticals Corp (CSE: ATT) (OTC: ATTBF) is powering up … [Read more...]